ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Serum N-terminal pro-B-type natriuretic peptide and cystatin C for acute kidney injury detection in critically ill adults in China: a prospective, observational study

Deng, Jia; He, Linling; Liang, Yufan; Hu, Linhui; Xu, Jing; Fang, Heng; Li, Ying; Chen, Chunbo*广东省人民医院; 广东医学院; 南方医科大学; 汕头大学
BMJ Open2023-1DOI: 10.1136/bmjopen-2022-063896
4阅读
引用收藏
分享

摘要

ObjectiveSerum N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cystatin C (sCysC) are available clinically and beneficial in diagnosing acute kidney injury (AKI). Our purpose is to identify the performance of their combined diagnosis for AKI in critically ill patients.DesignA prospectively recruited, observational study was performed.SettingAdults admitted to the intensive care unit of a tertiary hospital in China.ParticipantsA total of 1222 critically ill patients were enrolled in the study.Main outcome measuresTo identify the performance of the combined diagnosis of serum NT-proBNP and sCysC for AKI in critically ill patients. The area under the receiver operating characteristic curve (AUC-ROC), category-free net reclassification index (NRI) and incremental discrimination improvement (IDI) were utilised for comparing the discriminative powers of a combined and single biomarker adjusted model of clinical variables enriched with NT-proBNP and sCysC for AKI.ResultsAKI was detected in 256 out of 1222 included patients (20.9%). AUC-ROC for NT-proBNP and sCysC to detect AKI had a significantly higher accuracy than any individual biomarker (p<0.05). After multivariate adjustment, a level of serum NT-proBNP >= 204 pg/mL was associated with 3.5-fold higher odds for AKI compared with those below the cut-off value. Similar results were obtained for sCysC levels (p<0.001). To detect AKI, adding NT-proBNP and sCysC to a clinical model further increased the AUC-ROC to 0.859 beyond that of the clinical model with or without sCysC (p<0.05). Moreover, the addition of these two to the clinical model significantly improved risk reclassification of AKI beyond that of the clinical model alone or with single biomarker (p<0.05), as measured by NRI and IDI.ConclusionsIn critically ill individuals, serum NT-proBNP, sCysC and clinical risk factors combination improve the discriminative power for diagnosing AKI.

学科与关键词

关键词
acute renal failureadult intensive & critical carenephrology
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BMJ Open
发表日期
2023-01
卷期
第 13 卷, 第 1 期
页码
e063896
DOI
10.1136/bmjopen-2022-063896
语言
ENGLISH
成果收录
SCIE

作者

  • D

    Deng, Jia (第一作者)

    guangdong prov peoples hosp · southern med univ · 2 · dalian med univ

  • H

    He, Linling

    shantou univ · guangdong prov peoples hosp · southern med univ

查看全部 8 位作者收起作者
  • L

    Liang, Yufan

    guangdong med univ

  • H

    Hu, Linhui

  • X

    Xu, Jing

    guangdong prov peoples hosp · southern med univ

  • F

    Fang, Heng

    guangdong prov peoples hosp · southern med univ

  • L

    Li, Ying

    guangdong prov peoples hosp · southern med univ

  • C

    Chen, Chunbo (通讯)

    guangdong prov peoples hosp · southern med univ · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417